Antiemetic guidelines: are they being used?

This publication has 32 references indexed in Scilit:

• The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants
  Supportive Care in Cancer, 2004
• Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting
  Cancer, 2003
• Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
  European Journal Of Cancer, 2003
• ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery
  American Journal of Health-System Pharmacy, 1999
• Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference
  Annals of Oncology, 1998
• 5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting
  Drugs, 1998
• The Area Postrema and Vomiting
  Frontiers in Neuroendocrinology, 1994
• Mechanism of the Anti-Emetic Activity of 5-HT3 Receptor Antagonists
  Oncology, 1992
• PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST
  The Lancet, 1987
• Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
  New England Journal of Medicine, 1981